Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
Bonus plan approved
Inv. presentation
Acq. announced
Director departure
|
|
CUBIST PHARMACEUTICALS INC (CBST)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/01/2013 |
8-K
| Investor presentation|
Docs:
|
"Agreement and Plan of Merger, among Cubist Pharmaceuticals, Inc., BRGO Corporation and Trius Therapeutics, Inc. Schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The registrant will furnish copies of any such schedules to the U.S. Securities and Exchange Commission upon request",
"Form of Contingent Value Rights Agreement, to be entered into between Cubist Pharmaceuticals, Inc. and Broadridge Corporate Issuer Solutions, Inc",
"Form of Tender and Voting Agreement, by and among Cubist Pharmaceuticals, Inc. and the directors and certain officers of Trius Therapeutics, Inc. and their stockholder affiliates",
"Investor Presentation Slideshow, July 30, 2013" |
|
|
|